(G) Genpact - Overview

Sector: Technology | Industry: Information Technology Services | Exchange: NYSE (USA) | Market Cap: 4.924m USD | Total Return: -33% in 12m

Business Outsourcing, Data Analytics, Artificial Intelligence, Financial Operations

Total Rating 51

Safety 79

Buy Signal 0.03

Information Technology Services
Industry Rotation: +5.3

Market Cap: 4.92B
Avg Turnover: 113M

Risk 3d forecast

Volatility36.1%

VaR 5^th Pctl5.50%

VaR vs Median-9.90%

Reward TTM

Sharpe Ratio-1.15

Rel. Str. IBD5.2

Rel. Str. Peer Group18.8

Character TTM

Beta0.646

Beta Downside0.930

Hurst Exponent0.495

Drawdowns 3y

Max DD46.85%

CAGR/Max DD-0.15

CAGR/Mean DD-0.52

EPS (Earnings per Share)

EPS CAGR: 9.39%
EPS Trend: 89.4%

Last SUE: 3.07
Qual. Beats: 7

Revenue

Rev. CAGR: 4.75%
Rev. Trend: 96.1%

Last SUE: 0.84
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: G Genpact

Genpact Limited is a global professional services firm specializing in business process outsourcing (BPO) and information technology services. The company operates through three primary segments: Financial Services, Consumer and Healthcare, and High Tech and Manufacturing. Its service portfolio includes digital operations, data analytics, and artificial intelligence integration designed to automate enterprise functions such as finance, accounting, and supply chain management.

The company utilizes a Global Delivery Model, leveraging labor arbitrage and specialized hubs in regions like India and Latin America to provide 24/7 operational support to multinational corporations. As a firm within the Data Processing & Outsourced Services sub-industry, Genpact focuses on long-term service contracts that often include high switching costs for clients due to the deep integration of proprietary technology into their core workflows. For a deeper look at the fundamental metrics driving this business model, consider exploring the data on ValueRay.

Founded in 1997 as a captive unit of General Electric before becoming an independent entity, Genpact now serves a diverse client base across North America, Asia, and Europe. Its offerings extend beyond basic back-office support to include complex regulatory compliance, risk modeling, and end-to-end claims management for the insurance and healthcare sectors.

Headlines to Watch Out For

AI-led automation reduces headcount requirements and improves digital operations margins
Enterprise spending on generative AI integration fuels high-tech segment revenue growth
Financial services sector volatility impacts demand for mortgage and compliance outsourcing
Competitive pricing pressures in traditional BPO markets strain overall service profitability
Global delivery model shift toward nearshore centers increases operational cost structures

Piotroski VR‑10 (Strict) 8.0

Net Income: 569.6m TTM > 0 and > 6% of Revenue
FCF/TA: 0.12 > 0.02 and ΔFCF/TA -0.40 > 1.0
NWC/Revenue: 18.97% < 20% (prev 23.73%; Δ -4.76% < -1%)
CFO/TA 0.13 > 3% & CFO 748.9m > Net Income 569.6m
Net Debt (1.18b) to EBITDA (874.3m): 1.35 < 3
Current Ratio: 1.69 > 1.5 & < 3
Outstanding Shares: last quarter (172.8m) vs 12m ago -3.13% < -2%
Gross Margin: 36.43% > 18% (prev 0.36%; Δ 3.61k% > 0.5%)
Asset Turnover: 98.20% > 50% (prev 99.10%; Δ -0.90% > 0%)
Interest Coverage Ratio: 13.42 > 6 (EBITDA TTM 874.3m / Interest Expense TTM 59.3m)

Altman Z'' 3.15

A: 0.17 (Total Current Assets 2.41b - Total Current Liabilities 1.43b) / Total Assets 5.62b
B: 0.26 (Retained Earnings 1.44b / Total Assets 5.62b)
C: 0.15 (EBIT TTM 796.1m / Avg Total Assets 5.26b)
D: 0.14 (Book Value of Equity 453.6m / Total Liabilities 3.14b)
Altman-Z'' Score: 3.15 = A

Beneish M -3.06

DSRI: 1.00 (Receivables 1.31b/1.23b, Revenue 5.16b/4.85b)
GMI: 0.97 (GM 36.43% / 35.51%)
AQI: 0.97 (AQ_t 0.51 / AQ_t-1 0.52)
SGI: 1.06 (Revenue 5.16b / 4.85b)
TATA: -0.03 (NI 569.6m - CFO 748.9m) / TA 5.62b)
Beneish M-Score: -3.06 (Cap -4..+1) = AA

What is the price of G shares? As of May 18, 2026, the stock is trading at USD 29.05 with a total of 5,553,921 shares traded.
Over the past week, the price has changed by -10.78%, over one month by -21.34%, over three months by -22.63% and over the past year by -33.03%.

Is G a buy, sell or hold? Genpact has received a consensus analysts rating of 3.91. Therefore, it is recommended to buy G.

StrongBuy: 4
Buy: 2
Hold: 5
Sell: 0
StrongSell: 0

What are the forecasts/targets for the G price?

Analysts Target Price	42.7	47.1%

Genpact (G) - Fundamental Data Overview as of 18 May 2026

P/E Trailing = 8.911
P/E Forward = 18.315
P/S = 0.9541
P/B = 2.2297
P/EG = 1.1623
Revenue TTM = 5.16b USD
EBIT TTM = 796.1m USD
EBITDA TTM = 874.3m USD
Long Term Debt = 1.20b USD (from longTermDebt, last fiscal year)
Short Term Debt = 439.4m USD (from shortTermDebt, last quarter)
Debt = 1.76b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.18b USD (from netDebt column, last quarter)
Enterprise Value = 5.75b USD (4.92b + Debt 1.76b - CCE 928.1m)
Interest Coverage Ratio = 13.42 (Ebit TTM 796.1m / Interest Expense TTM 59.3m)
EV/FCF = 8.64x (Enterprise Value 5.75b / FCF TTM 666.3m)
FCF Yield = 11.58% (FCF TTM 666.3m / Enterprise Value 5.75b)
FCF Margin = 12.91% (FCF TTM 666.3m / Revenue TTM 5.16b)
Net Margin = 11.04% (Net Income TTM 569.6m / Revenue TTM 5.16b)
Gross Margin = 36.43% ((Revenue TTM 5.16b - Cost of Revenue TTM 3.28b) / Revenue TTM)
Gross Margin QoQ = 36.89% (prev 36.56%)
Tobins Q-Ratio = 1.02 (Enterprise Value 5.75b / Total Assets 5.62b)
Interest Expense / Debt = 0.66% (Interest Expense 11.6m / Debt 1.76b)
Taxrate = 23.71% (46.0m / 194.0m)
NOPAT = 607.3m (EBIT 796.1m * (1 - 23.71%))
Current Ratio = 1.69 (Total Current Assets 2.41b / Total Current Liabilities 1.43b)
Debt / Equity = 0.71 (Debt 1.76b / totalStockholderEquity, last quarter 2.48b)
Debt / EBITDA = 1.35 (Net Debt 1.18b / EBITDA 874.3m)
Debt / FCF = 1.77 (Net Debt 1.18b / FCF TTM 666.3m)
Total Stockholder Equity = 2.54b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.84% (Net Income 569.6m / Total Assets 5.62b)
RoE = 22.44% (Net Income TTM 569.6m / Total Stockholder Equity 2.54b)
RoCE = 21.32% (EBIT 796.1m / Capital Employed (Equity 2.54b + L.T.Debt 1.20b))
RoIC = 15.55% (NOPAT 607.3m / Invested Capital 3.91b)
WACC = 6.22% (E(4.92b)/V(6.68b) * Re(8.26%) + D(1.76b)/V(6.68b) * Rd(0.66%) * (1-Tc(0.24)))
Discount Rate = 8.26% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -100.00 | Cagr: -2.59%
[DCF] Terminal Value 87.31% ; FCFF base≈639.8m ; Y1≈761.5m ; Y5≈1.20b
[DCF] Fair Price = 184.2 (EV 32.41b - Net Debt 1.18b = Equity 31.23b / Shares 169.5m; r=6.22% [WACC]; 5y FCF grow 20.27% → 3.0% )
EPS Correlation: 89.40 | EPS CAGR: 9.39% | SUE: 3.07 | # QB: 7
Revenue Correlation: 96.13 | Revenue CAGR: 4.75% | SUE: 0.84 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.97 | Chg30d=-0.92% | Revisions=-20% | Analysts=11
EPS next Quarter (2026-09-30): EPS=1.05 | Chg30d=+0.26% | Revisions=+0% | Analysts=11
EPS current Year (2026-12-31): EPS=4.07 | Chg30d=+1.41% | Revisions=+69% | GrowthEPS=+11.6% | GrowthRev=+7.0%
EPS next Year (2027-12-31): EPS=4.48 | Chg30d=+0.94% | Revisions=+50% | GrowthEPS=+9.9% | GrowthRev=+7.3%
[Analyst] Revisions Ratio: +69%